Healthcare -
Biotechnology - NASDAQ - US
$ 0.6901
-13.5 %
$ 8.95 M
Market Cap
-0.85
P/E
ABVC - COST OF REVENUE
Cost of Revenue ABVC - ABVC BioPharma, Inc.
302 K
LAST VALUE
670.62%
2 YEAR CAGR
10.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR